NO20073105L - Pyridazinonforbindelser - Google Patents

Pyridazinonforbindelser

Info

Publication number
NO20073105L
NO20073105L NO20073105A NO20073105A NO20073105L NO 20073105 L NO20073105 L NO 20073105L NO 20073105 A NO20073105 A NO 20073105A NO 20073105 A NO20073105 A NO 20073105A NO 20073105 L NO20073105 L NO 20073105L
Authority
NO
Norway
Prior art keywords
pyridazinone
compounds
hepatitis
infections
virus
Prior art date
Application number
NO20073105A
Other languages
English (en)
Inventor
Stephen E Webber
Yuefen Zhou
Liansheng Li
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Publication of NO20073105L publication Critical patent/NO20073105L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen angår pyridazinonforbindelser og farmasøytiske blandinger inneholdende slike forbindelser som er anvendelige for behandling av infeksjoner ved hepatitt C virus.
NO20073105A 2004-12-17 2007-06-18 Pyridazinonforbindelser NO20073105L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63661604P 2004-12-17 2004-12-17
PCT/US2005/045588 WO2006066079A2 (en) 2004-12-17 2005-12-16 Pyridazinone compounds

Publications (1)

Publication Number Publication Date
NO20073105L true NO20073105L (no) 2007-09-13

Family

ID=36588590

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073105A NO20073105L (no) 2004-12-17 2007-06-18 Pyridazinonforbindelser

Country Status (21)

Country Link
US (1) US7425552B2 (no)
EP (1) EP1824847A2 (no)
JP (1) JP2008526687A (no)
KR (1) KR20070100743A (no)
CN (1) CN101137651A (no)
AP (1) AP2007004040A0 (no)
AR (1) AR054214A1 (no)
AU (1) AU2005316396A1 (no)
CA (1) CA2589527A1 (no)
CR (1) CR9204A (no)
EA (1) EA200701297A1 (no)
GT (1) GT200500373A (no)
IL (1) IL183510A0 (no)
MX (1) MX2007007264A (no)
NO (1) NO20073105L (no)
PA (1) PA8657001A1 (no)
PE (1) PE20060871A1 (no)
SV (1) SV2006002347A (no)
TW (1) TW200635596A (no)
UY (1) UY29266A1 (no)
WO (1) WO2006066079A2 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2007004040A0 (en) 2004-12-17 2007-06-30 Anadys Pharmaceuticals Inc Pyridazinone compounds
AP2007004244A0 (en) 2005-05-10 2007-12-31 Intermune Inc Method of modulating stress-activated protein kinase system
WO2008051637A2 (en) * 2006-06-22 2008-05-02 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
WO2007150001A1 (en) * 2006-06-22 2007-12-27 Anadys Pharmaceuticals, Inc. Pyrro[1,2-b]pyridazinone compounds
TW200840572A (en) 2006-12-12 2008-10-16 Anadys Pharmaceuticals Inc 5,6-dihydro-1H-pyridin-2-one compounds
WO2008073987A1 (en) * 2006-12-12 2008-06-19 Anadys Pharmaceuticals, Inc. Saturated fused [1,2-b] pyridazinone compounds
US20080188466A1 (en) * 2006-12-21 2008-08-07 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
US20080275032A1 (en) * 2006-12-29 2008-11-06 Yuefen Zhou Pyridazinone compounds
US20080227774A1 (en) * 2007-03-15 2008-09-18 Frank Ruebsam 5,5-disubstituted-indolizinone compounds
UA100120C2 (en) * 2007-04-03 2012-11-26 Анадис Фармасьютикалз, Инк. 5,6-dihydro-1h-pyridin-2-one compounds
MX2009011930A (es) 2007-05-04 2009-11-18 Vertex Pharma Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c.
WO2008144500A2 (en) * 2007-05-17 2008-11-27 Anadys Pharmaceuticals, Inc. 1-methyl-benzo[1,2,4]thiadiazine, 1-oxide derivatives
ITMI20071012A1 (it) * 2007-05-18 2008-11-19 St Microelectronics Srl Dispositivo di memoria migliorato a veloce programmazione
US7834009B2 (en) * 2007-08-27 2010-11-16 Anadys Pharmaceuticals, Inc. 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
TWI438206B (zh) 2008-06-10 2014-05-21 Anadys Pharmaceuticals Inc 〔１，２，４〕噻二１，１二氧化物化合物
WO2010042834A1 (en) 2008-10-09 2010-04-15 Anadys Pharmaceuticals, Inc. A method of inhibiting hepatitis c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds
TW201026675A (en) * 2008-10-09 2010-07-16 Anadys Pharmaceuticals Inc 5,6-dihydro-1H-pyridin-2-one compounds
WO2010082050A1 (en) 2009-01-16 2010-07-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections
WO2011045271A1 (de) 2009-10-15 2011-04-21 Bayer Cropscience Ag Herbizid wirksame heterocyclylsubstituierte pyridazinone
KR20120092142A (ko) * 2009-10-28 2012-08-20 애나디스 파마슈티칼스, 인코포레이티드 중수소화 5,6-다이하이드로-1ｈ-파이리딘-2-온 화합물
MX2012007076A (es) 2009-12-18 2012-07-20 Boehringer Ingelheim Int Terapia combinada de hcv.
US20120321590A1 (en) 2011-04-06 2012-12-20 Anadys Pharmaceuticals, Inc. Bridged polycyclic compounds
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014121417A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
WO2014121418A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
WO2014121416A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
PE20211761A1 (es) * 2014-04-29 2021-09-07 Fmc Corp Herbicidas de piridazinona
KR102624961B1 (ko) * 2015-12-07 2024-01-16 디아이씨 가부시끼가이샤 중합성 화합물의 제조 방법
CN105999097A (zh) * 2016-07-08 2016-10-12 王恩禄 一种治疗乙肝的中药组合物
EP3980072A4 (en) * 2019-06-05 2023-06-14 University of Georgia Research Foundation COMPOSITIONS AND METHODS FOR THE PREVENTION OR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION RELATED TO HUMAN IMMUNE DEFICIENCY VIRUS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
WO2001085172A1 (en) 2000-05-10 2001-11-15 Smithkline Beecham Corporation Novel anti-infectives
US20060003346A1 (en) 2000-08-11 2006-01-05 Ashok Amin Method for treating hepatitis
AR036081A1 (es) 2001-06-07 2004-08-11 Smithkline Beecham Corp Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos
WO2003059356A2 (en) 2001-10-30 2003-07-24 Smithkline Beecham Corporation Novel anti-infectives
US7601709B2 (en) 2003-02-07 2009-10-13 Enanta Pharmaceuticals, Inc. Macrocyclic hepatitis C serine protease inhibitors
US7439246B2 (en) 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
WO2006021340A1 (en) 2004-08-23 2006-03-02 F.Hoffmann-La Roche Ag Heterocyclic antiviral compounds
AP2007004040A0 (en) 2004-12-17 2007-06-30 Anadys Pharmaceuticals Inc Pyridazinone compounds
WO2006115221A1 (ja) 2005-04-21 2006-11-02 Nippon Shinyaku Co., Ltd. フタラジノン誘導体及びその医薬
MX2007013415A (es) * 2005-05-04 2008-01-15 Hoffmann La Roche Compuestos antivirales heterociclicos.
WO2007150001A1 (en) 2006-06-22 2007-12-27 Anadys Pharmaceuticals, Inc. Pyrro[1,2-b]pyridazinone compounds

Also Published As

Publication number Publication date
UY29266A1 (es) 2006-07-31
KR20070100743A (ko) 2007-10-11
IL183510A0 (en) 2007-09-20
MX2007007264A (es) 2007-08-14
EA200701297A1 (ru) 2007-12-28
AR054214A1 (es) 2007-06-13
WO2006066079A2 (en) 2006-06-22
PE20060871A1 (es) 2006-09-04
TW200635596A (en) 2006-10-16
EP1824847A2 (en) 2007-08-29
JP2008526687A (ja) 2008-07-24
AP2007004040A0 (en) 2007-06-30
SV2006002347A (es) 2006-08-25
CN101137651A (zh) 2008-03-05
US20060189602A1 (en) 2006-08-24
CR9204A (es) 2007-09-06
AU2005316396A1 (en) 2006-06-22
WO2006066079A3 (en) 2006-12-14
CA2589527A1 (en) 2006-06-22
US7425552B2 (en) 2008-09-16
GT200500373A (es) 2006-10-02
PA8657001A1 (es) 2006-08-03

Similar Documents

Publication Publication Date Title
NO20090438L (no) Hepatit C virus inhibitorer
EA200701297A1 (ru) Соединения пиридазинона
EA200800178A1 (ru) Ингибиторы вируса гепатита с (hcv)
NO20090447L (no) Hepatittt C virusinhibitorer
NO20090453L (no) Hepatitt C Virusinhibitorer
EA200800371A1 (ru) Ингибиторы ns3 протеазы вгс
EA201001273A1 (ru) Ингибиторы вируса гепатита с
NO20092053L (no) HCV NS3-proteaseinhibitorer
NO20081086L (no) Makrosykliske peptider som HCV NS3-proteaseinhibitorer
EA200970916A1 (ru) Соединения 5,6-дигидро-1н-пиридин-2-она
ATE551337T1 (de) Inhibitoren des hepatitis-c-virus
EA201000201A1 (ru) Азотсодержащие бициклические химические вещества для лечения вирусных инфекций
EA201101082A1 (ru) Ингибиторы вируса гепатита с
WO2008057208A3 (en) Hcv ns3 protease inhibitors
WO2008051514A3 (en) Hcv ns3 protease inhibitors
WO2008051475A3 (en) Hcv ns3 protease inhibitors
EA201270622A1 (ru) Ингибиторы вируса гепатита с
WO2006119061A3 (en) Hcv ns3 protease inhibitors
EA200870164A1 (ru) Лечение вирусного гепатита
SI1987038T1 (sl) Hcv ns5b inhibitorji
WO2008073982A3 (en) 5,6-dihydro-1h-pyridin-2-one compounds
WO2008051637A3 (en) Pyridazinone compounds
UA90909C2 (en) Hcv ns3 protease inhibitors
UA95990C2 (en) Hcv ns3 protease inhibitors
TH105715A (th) สารยับยั้งไวรัสตับอักเสบ c

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application